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The aim of this study was to determine the effects of supplementing unprotected dietary unsaturated fatty acids (UFAs) from
different plant oils on gene expression in the mammary gland of grazing dairy cows. A total of 28 Holstein–Friesian dairy cows in
mid-lactation were blocked according to parity, days in milk, milk yield and fat percentage. The cows were then randomly assigned
to four UFA sources based on rapeseed, soybean, linseed or a mixture of the three oils for 23 days, after which, all 28 cows were
switched to a control diet for an additional 28 days. On the last day of both periods, mammary gland biopsies were taken to study
genome-wide differences in gene expression on Affymetrix GeneChipR Bovine Genome Arrays (no. 900493) by ServiceXS (Leiden,
The Netherlands). Supplementation with UFAs resulted in increased milk yield but decreased milk fat and protein percentages.
Furthermore, the proportion of de novo fatty acids (FAs) in the milk was reduced, whereas that of long-chain FAs increased.
Applying a statistical cut-off of false discovery rate of q-values ,0.05 together with an absolute fold change of 1.3, a total of 972
genes were found to be signiﬁcantly affected through UFA supplementation, indicating that large transcriptional adaptations
occurred in the mammary gland when grazing dairy cows were supplemented with unprotected dietary UFA. Gene sets related to
cell development and remodeling, apoptosis, nutrient metabolic process, as well as immune system response were predominantly
downregulated during UFA supplementation. Such molecular knowledge on the physiology of the mammary gland might provide
the basis for further functional research on dairy cows.
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Implications
Milk composition and gene expression in the mammary
gland tissue were evaluated in grazing dairy cows supple-
mented with different unsaturated fatty acids (UFA). The UFA
supplementation improves the health and nutrition quality
aspects of dairy milk, besides affecting the gene networks
expression signature associated with cellular growth and
proliferation, cell death, signaling, nutrient metabolism and
immune response. This molecular knowledge on the phy-
siology of the mammary gland might provide the basis for
more detailed functional studies for future research.
Introduction
The growing awareness over the last decade of the asso-
ciation between diet and health has led nutritional quality
to become a relevant factor in consumers’ food choices.
A major development has been the recognition that certain
lipids in dairy milk, such as oleic acid, some isomers of the
conjugated linoleic acid (CLA) and a-linolenic acid (ALA),
can improve human health status and prevent diseases
(Bauman et al., 2006). Supplementing the diet of lactating
dairy cows with different unsaturated fatty acids (UFA) is
a signiﬁcant attempt to improve milk fat composition for
human consumption (Mansbridge and Blake, 1997; Harvatine
and Bauman, 2006). Recently functional genomics studies,
based on quantitative real-time polymerase chain reaction
(qRT-PCR), have described the effects of dietary UFA on the
expression of a number of candidate genes in the mammary
gland involved in lipid metabolism (Harvatine and Bauman,
2006; Bauman et al., 2008; Bionaz and Loor, 2008a and
2008b; Harvatine et al., 2009; Kadegowda et al., 2009).
There is signiﬁcant evidence that feeding cows with UFA-rich
diets reduces the mammary mRNA abundance of acetyl-
coenzyme A (CoA) carboxylase (ACACA), fatty acid synthase
(FASN), and stearoyl-CoA desaturase 1 (SCD1), as well as
the transcription factor sterol regulatory element binding- E-mail: nuria.mach@wur.nl
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factor 1 (SREBP1) and peroxisome proliferator-activated
receptor-g (PPARG; Bauman et al., 2006; Thering et al.,
2009). However, information on the genome-wide expres-
sion of genes in the mammary gland tissue of dairy cows
supplemented with different dietary unprotected UFA is still
lacking. Therefore, it is not known yet whether dietary
unprotected UFA supplementation also affects processes not
related to lipid metabolism and the expression of less
obvious genes.
Although qRT-PCR is a powerful approach to obtain a
quantitative and highly precise estimates of gene expres-
sion; interest in microarray technologies for measuring gene
expression has exploded in recent years (Sinicropi et al.,
2007). The biggest advantage of microarray technology is its
unbiased approach and the large number of transcripts that
can be quantiﬁed in a single experiment. Microarray studies
provide the ability to monitor the genome-wide expression
of genes and to discover target genes that would not have
been detected by other more focussed methods (Sinicropi
et al., 2007). In addition, they provide a holistic view of the
molecular events that occur when the mammary gland
adapts to changes in the supply of dietary lipids, and con-
sequent changes in the milk yield and composition through
feeding strategies. Therefore, the recent development of
microarray platforms for bovines in combination with bioin-
formatics has gained much attention in dairy science to
discover genes and molecular pathways related to changes
in the environment and/or phenotypic characteristics. Here,
these developments have been used to determine the effects
of unprotected dietary UFA from different plant oils on the
global expression pattern of genes in the mammary gland
tissue of grazing dairy cows in order to improve our under-
standing of mammary gland physiology.
Material and methods
Animals and diets
A total of 28 Holstein–Friesian dairy cows in mid-lactation
were blocked according to parity (2.46 0.63 births), days in
milk (1536 32.8 days), milk yield (25.76 1.08 kg/day) and
milk fat percentage (4.3%6 0.12%). Cows were then ran-
domly assigned to treatment groups based on one of the
four dietary treatments (n5 7 per dietary treatment). The
dietary treatments consisted of a basal diet supplemented
with either 2.7% of rapeseed oil, 2.7% of soybean oil, 2.7%
of linseed oil or 2.7% of a proportional mixture of the three
oils on a dry matter (DM) basis (Table 1). Rapeseed oil was
chosen because it is an oil rich in c9-18:1 (oleic acid),
whereas soybean oil was chosen as an oil rich in c9,c12-18:2
(linoleic acid) and the linseed oil as an oil rich in ALA.
Overall, the concentration and the different oil sources used
in the experiment are typically present in dairy cows rations.
The oil supplements were included in the concentrate, which
was fed, together with corn silage and grass silage, as a
mixed ration (MR; Table 1). Corn silage, grass silage and
concentrates represented 52%, 12% and 36% of the MR
DM. In addition to the MR, each cow received 1 kg of a
commercial standard concentrate per day through automatic
feeders in the milking parlor. Cows were fed the MR indoors
at night, and were grazed on pasture composed of ryegrass
(Lolium perenne L.), with approximately 20% white clover
(Trifolium repens L.) during the day (from 0800 h to 1600 h).
The average paddock size was 5 ha and the stocking rate
was 16 cows/ha. Cows were fed the MR at a level of about
14.5 kg of DM/cow per day, and grazed at a daily herbage
intake of approximately 5.5 kg of DM/cow. After the ﬁrst
23 days (experimental period I), all cows were switched to a
control diet without oil supplementation for an additional
28 days (experimental period II; Tables 1 and 2). This design,
in which, each cow got both of the intervention in sequence,
was chosen because it reduces variability of gene expression
between cows due to heterogeneity in genetic background,
and increases the statistical power to detect differential gene
expression to a speciﬁed Type I error rate. A disadvantage of
this design is that the effects attributed to UFA supple-
mentation may be confounded with effects due to difference
(of 28 days) in lactation stage (see Discussion). Cows were
milked twice a day in the milking parlor at the facility. Each of
the four groups of cows was kept indoors in separated pens.
Individual milk production and MR intake per treatment
group were recorded daily during both experimental periods.
The pasture intake estimation was limited by the variation in
the sward heights before grazing (at 0800 h) and after
grazing (1600 h) on the last 3 days of each period, using a
rising plate meter (weight: 350 g, diameter: 0.5m, standing
pressure ca. 17.5 N/m2; Eijkelkamp, Giesbeek, the Nether-
lands). Samples of individual feedstuffs, including pasture
and MR were taken during the last 3 days of the experi-
mental periods, and were then analyzed for nutrient com-
position and fatty acid (FA) proﬁle. Ingredients of the
concentrates and MR are presented in Table 1, whereas
chemical composition of concentrates and the chemical and
FA composition of the MR are presented in Table 2. The
chemical and FA composition of the pasture are presented
in Table S1. In addition, on the last day of experimental
periods I and II, two consecutive milk samples (0700 h and
1700 h milking) were obtained and pooled (0.6 : 0.4 ratio).
One aliquot was stored at 48C until analysis of fat, protein
and lactose percentage, and another aliquot was frozen
at 2208C until analysis for FA composition by gas chroma-
tography. Fat, protein and lactose percentage was deter-
mined using mid-infrared spectrometry (International
Standard Organisation (ISO) 9622, 1999; Qlip NV, Zutphen,
the Netherlands).
On the last day of both experimental periods, biopsies
were carried out before the afternoon milking. A core of
secretory tissue (750 to 1000mg) of mammary tissue from
each cow was obtained by surgical biopsy from the midpoint
section of a rear quarter according to the method of Farr
et al. (1996). The capsular end of the core was deleted to
reduce the gene expression heterogeneity as a result of its
greater amount of connective tissue (Farr et al., 1996). Tissue
biopsies were snap-frozen in liquid nitrogen and stored at
2808C until RNA extraction.
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To prevent local infection, a single intramammary injection of
amoxicillin and clavulic acid (AvuloxilR ; Pﬁzer Animal Health,
Capelle a/d IJssel, the Netherlands) was applied in the affected
rear quarter. Furthermore, a single intramuscular dose of cef-
tiofur hydrochloride (ExcenelR ; Pﬁzer Animal Health, Capelle
a/d IJssel, the Netherlands) was given immediately after the
biopsy. Within 2 h of the biopsy, cows were machine-milked
and hand-stripped as needed to remove all intramammary
blood clots, according to the method of Farr et al. (1996). This
experiment was conducted at the Cranendonck Research Farm,
the Netherlands, between September 26 and November 14,
2007, and procedures were approved by the Animal Care and
Ethics Committee of Wageningen UR Livestock Research,
Lelystad (the Netherlands).
Chemical analysis
Composite samples of feeds from the last 3 days of each
experimental period were analyzed for DM content (ISO
6496, 1998), ash (ISO 5984, 2002), Kjeldahl N (ISO 5983,
2005), ADF (Van Soest, 1973) and NDF according to a
modiﬁed method of Van Soest et al. (1991) with additional
incubations in a-amylase and protease as described by
Goelema et al. (1998). Crude fat was determined by Berntrop
method with acid hydrolysis (ISO 6492, 1999).
FA analysis
The FA of milk and feedstuffs were extracted with
chloroform–methanol (2 : 1, v/v) and transesteriﬁed to fatty
acid methyl esters (FAME) by vortexing with sodium metha-
nolate in methanol (30%). Then, FAME were used for gas
chromatography analysis (Trace GC Ultra, Waltham, MA, USA).
Speciﬁc details with regard to the analysis of FA in milk and
feedstuffs are presented in the Supplementary materials. The
proportion of de novo synthesis of FA was estimated based on
the assumption that all FAs from 4-carbon to 14-carbon and
only 50% of 16-carbon FAs were synthesized by the mammary
gland (Delamaire and Guinard-Flament, 2006). In addition, the
proportion of long-chain fatty acid (LCFA) was calculated by
the sum of 50% 16-carbon and all the 18- to 24-carbon FA
(Delamaire and Guinard-Flament, 2006).
RNA isolation, processing and microarray analysis
Total RNA from mammary gland tissue (50 to 100mg) was iso-
lated using TRIzol reagent (Invitrogen, Breda, the Netherlands),
Table 1 Ingredients of the experimental diets and the concentrates offered in the mixed ration
UFA-enriched treatment
Item Control treatment Rapeseed oil Soybean oil Linseed oil Mixture 1 : 1 : 1
Ingredients in the mixed rations (g/kg)
Corn silage 520 520 520 520 520
Grass silage 120 120 120 120 120
Concentrate1 360 360 360 360 360
Ingredients in the concentrates (g/kg)
Triticale – 333.6 333.6 333.6 333.6
Rapeseed meal – 195.0 195.0 195.0 195.0
Soybean meal – 102.0 102.0 102.0 102.0
Dried brewers grain – 79.0 79.0 79.0 79.0
Rapeseed oil – 75.0 – – 25.0
Soybean oil – – 75.0 – 25.0
Linseed oil – – – 75.0 25.0
Rapeseed meal 108.1 68.0 68.0 68.0 68.0
Citrus pulp 370.0 60.0 60.0 60.0 60.0
Soybean meal – 47.0 47.0 47.0 47.0
Palm kernel expeller 227.3 – – – –
Sugar beet molasses 101.0 – – – –
Coconut expeller 64.8 – – – –
Wheat gluten feed 45.0 – – – –
Wheat middlings 31.0 – – – –
Soybean hulls 29.3 – – – –
Protapec2 13.7 – – – –
Calcium carbonate 2.0 16.3 16.3 16.3 16.3
Sodium choloride 2.4 10.5 10.5 10.5 10.5
Magnesium oxide (90%) 3.4 4.8 4.8 4.8 4.8
Urea – 4.5 4.5 4.5 4.5
Monocalcium phosphate – 2.3 2.3 2.3 2.3
Vitamin–mineral premix 2.0 2.0 2.0 2.0 2.0
UFA5 unsaturated fatty acids.
1Including the concentrate supplied through the automatic feeding station.
2Concentrated potato fruit juice mixed with soybean hulls.
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following the manufacturer’s instructions. The RNA purity
and concentrations were determined using a NanoDrop ND-
1000 spectrophotometer (Isogen, Maarssen, the Netherlands),
and the RNA quality was assessed using the BioAnalyzer
2100 (Agilent Technologies, Amsterdam, the Netherlands). The
RNA was judged as suitable for array hybridization because
they showed intact bands corresponding to the 18S and
28S ribosomal RNA subunits, displayed no RNA degradation
products, and presented an average RNA integrity number of
8.3260.05. The RNA of each biopsy was ampliﬁed, biotin-
labeled and hybridized to single dye Affymetrix GeneChipR
Bovine Genome Array (no. 900493) by ServiceXS (Leiden, the
Netherlands), as described in the users’ manual (Affymetrix
GeneChipR Expression Analysis Technical Manual, Santa
Clara, CA, USA). As the factorial design and analysis of
the microarray experiment is a reliable method to identify the
inﬂuence of multiple factors on the expression proﬁles of the
probe sets in the microarray (Xu and Faisal, 2010), a total of 56
one-color arrays were prepared, one array per RNA sample.
Brieﬂy, total RNA (2mg per sample) was reverse transcribed to
cDNA using a T7-oligo(dT) primer. Following second strand
cDNA synthesis, the double-stranded cDNA was puriﬁed as a
template for the subsequent in vitro transcription reaction.
Linearly ampliﬁed biotin-labeled cRNA was synthesized in the
presence of a biotin-labeled nucleotide analog/RNA mix. The
labeled cRNA was puriﬁed, fragmented and hybridized to the
arrays at 458C for 16 h with constant rotational mixing at
60 r.p.m. Washing and staining of the arrays was carried out
using the Affymetrix GeneChipR Fluidics Station 450 (Santa
Clara, CA, USA). The arrays were scanned using an Affymetrix
GeneChipR Scanner 7G (Santa Clara, CA, USA) and Affymetrix
GeneChipR Operating Software version 1.4, following the
GeneChip’s speciﬁcations. After scanning, the Affymetrix Gen-
eChip Command Console Software automatically acquired and
analyzed image data and computed an intensity value for each
probe cell. A number of quality control parameters associated
Table 2 Chemical composition of the concentrates and chemical and FA composition of the mixed rations
UFA-enriched treatments
Item Control treatment Rapeseed oil Soybean oil Linseed oil Mixture 1 : 1 : 1
Chemical composition of concentrates (g/kg DM)
DM (g/kg) 911.7 891.1 900.5 904.1 901.0
Ash 87.6 81.2 79.3 86.1 84.9
CP 161.2 246.5 296.5 252.3 242.4
Crude fat 55.6 98.0 89.6 93.8 93.9
NDF 326.3 179.8 148.4 196.3 185.2
ADF 249.0 116.8 110.4 122.9 119.3
Starch 35.6 219.8 151.2 172.4 211.7
Sugars 120.0 73.0 105.8 87.1 72.3
Chemical composition of mixed rations (g/kg of DM)
DM (g/kg) 560.9 589.4 574.5 573.1 593.6
Ash 66.1 66.2 64.3 66.5 67.4
CP 132.2 162.8 180.0 164.9 161.4
Crude fat 40.5 55.8 52.9 54.3 54.4
NDF 356.4 305.9 294.0 310.3 307.7
ADF 227.7 187.0 181.3 185.1 188.0
Starch 182.4 227.4 214.7 223.4 224.2
Sugars 57.4 48.5 55.7 48.7 48.5
FA composition of mixed rations (g/100 g FA)
8:0 1.5 0.3 0.2 0.2 0.3
10:0 1.5 0.3 0.2 0.2 0.3
12:0 16.8 3.6 2.0 1.9 3.8
14:0 6.1 1.7 0.8 0.8 1.5
16:0 13.5 16.7 13.9 10.3 13.3
c9-16:1 0.2 1.1 0.2 0.2 0.5
18:0 2.7 4.0 3.3 3.2 3.5
c9-18:1 17.3 30.1 20.3 20.5 23.8
c11-18:1 0.9 2.2 1.3 1.6 1.8
c9,c12-18:2 30.6 32.3 47.2 29.3 35.2
18:3n-3 7.7 6.6 9.3 30.7 14.8
20:0 0.5 0.4 0.5 0.3 0.4
22:0 0.5 0.5 0.5 0.4 0.5
24:0 0.4 0.3 0.3 0.3 0.3
FA5 fatty acid; UFA5 unsaturated fatty acids; DM5 dry matter.
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with assay and hybridization performance were closely mon-
itored. Speciﬁc details with regard to these quality control
parameters are presented in the Supplementary materials.
Validation of differential gene expression by qRT-PCR
In order to validate microarray analysis, the following four
genes measured by microarray analysis were conﬁrmed by
qRT-PCR: FASN, fatty acid desaturase 1 (FADS1), fatty acid
desaturase 3 (FADS3) and SCD1. Brieﬂy, reverse transcription
of 1mg of the isolated total RNA (see section ‘RNA isolation,
processing and microarray analysis’) was performed in a 20-ml
reaction using Superscript III reverse transcriptase (Invitrogen,
Breda, the Netherlands), deoxynucleosides (Roche Diagnostics,
Almere, the Netherlands) and random hexamer primers (Roche
Diagnostics, Almere, the Netherlands) for 1 h at 508C according
to the manufacturer’s protocol (Invitrogen, Breda, the Nether-
lands). Templates were ampliﬁed after a preincubation for
10min at 958C, followed by ampliﬁcation for 40 cycles (10 s at
958C, 5 s at 608C and 5 s at 728C) on a LightCycler 1.2 Real-
Time PCR System by using FastStart DNA Master SYBR Green I
reagents (Roche Diagnostics, Almere, the Netherlands). All
reactions revealed a single product as determined by melting
curve analysis. Quantitative measurement was taken by
establishing a linear ampliﬁcation curve from serial dilutions of
cDNAs for corresponding genes, and efﬁciencies of the used
sets of primers were calculated to be at least 95%. Values
were calculated according to the comparative threshold cycle
method using 18SRNA as the endogenous reference gene.
Microarray data analysis
All microarray analysis including preprocessing, normalization
and statistical analysis was carried out using Bioconductor
packages (version 2.5) in R programming language (version
2.11). Data were quality assessed before and after normal-
ization using a number of built-in quality control methods
implemented in the Bioconductor affycoretools and asso-
ciated packages to identify eventual irregularities of array
hybridization, RNA degradation and data normalization.
Arrays were considered to be of sufﬁcient quality when they
showed not more than 10% of specks in Bioconductor’s Fitting
Probe Level Model (ﬁtPLM) images, were not deviating in RNA
degradation and density plots, and were not signiﬁcantly
deviating in Normalized Unscaled Standard Errors Plot and in
Relative Log Expression plots (data not shown). Upon rigorous
examination of the resulting diagnostic plots, all 56 micro-
arrays were included in further analysis. Affymetrix Gen-
eChipR uses a set of 11 to 20 oligonucleotide probes, each 25
bases long, to represent a single gene (Gautier et al., 2004).
The expression level for a single gene is the summary of the
data from the entire probe set (Gautier et al., 2004). In this
study, the expression levels of probe sets were summarized
using the library GeneChip content-corrected robust multichip
average algorithm ( Wu et al., 2004), employing the empirical
Bayes approach for background correction followed by
quantile normalization. As many of the original annotations
for the Affymetrix GeneChipR Bovine have been found to
be erroneous (Gautier et al., 2004), a custom chip deﬁnition
ﬁle (CDF; Bovine_Bt_REFSEQ version 12.0.0), available at
http://brainarray.mbni.med.umich.edu/Brainarray/Database/
CustomCDF/12.0.0/refseq.asp was used to re-annotate the
probes to new probe sets. Therefore, the original probe set
deﬁnitions were discarded and all probes were recomposed
into new probe sets by mapping each probe via their
sequence to unique genes available in Refseq genomics
resources. As these custom CDFs are based on the latest
genomic knowledge, the newly deﬁned probe sets perform
better, and allow for more reliable comparison of gene
expression. In addition, as genes are uniquely represented in
a custom CDF, bias toward genes represented by multiple
probe sets is avoided in gene-set enrichment (de Leeuw
et al., 2008). This resulted in gene expression values for
11 495 known genes with unique identiﬁers from 24128 tran-
scripts. All microarray experiment data are MIAME (Minimum
Information About a Microarray Experiment) compliant and has
been deposited in gene expression omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/; accession numbers GSE20909).
Statistical analyses
Milk yield and composition, as well as FA composition, were
analyzed using a mixed-effects ANOVA (release 9.1; Statis-
tical Analysis Software Institute Inc. Cary, NC, USA). The
model included UFA sources, UFA supplementation (experi-
mental periods), and the interaction between UFA sources
and UFA supplementation (experimental periods), as ﬁxed
effects and cow within pen as a random effect. When dif-
ferences between UFA sources were signiﬁcant (P, 0.05),
Tukey’s test was used to compare means. The same model
was used to analyze gene expression. The mixed-effects
ANOVA was chosen because when there are more than two
conditions to compare, the application of ANOVA F-test is
much powerful than a t-test (Cui and Churchill, 2003).
ANOVA considers the variability of the expression levels
within and among treatments. If the variability of the
expression of a gene among treatments is substantially
greater than the variability within treatments, this indicates
that the gene is differentially expressed. Lastly, the mixed-
effects ANOVA allows to treat the cow as a random effect,
which captures variability between individual cows within
the same condition (Churchill, 2004). Ollier et al. (2009) also
analyzed genome-wide expression in the mammary gland of
goats fed with diets differing in forage-to-concentrate ratio
supplemented or not with lipids by ANOVA, including diet,
period and animal group effects. However, in our study, the
expression of genes in mammary gland was not signiﬁcantly
affected by the different dietary unprotected UFA sources.
Therefore, this unstatistically signiﬁcant variable and the
interaction between UFA sources and UFA supplementa-
tion (experimental periods) were removed from the model.
The ﬁnal statistical model included UFA supplementation
(experimental periods) as ﬁxed effect and cow as a random
effect. The P-values were corrected for multiple testing using
a false discovery rate (FDR) method, which provides an
estimate of the fraction of false discoveries among the sig-
niﬁcant terms (Bunger et al., 2007). The list of differentially
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expressed genes was generated using a FDR, 5%
(q-value ,0.05) together with an absolute fold change (FC)
threshold of 1.3. In addition, three complementary methods
were applied to relate changes in gene expression to func-
tional changes. One method, provided via the ErmineJ
software program, was based on overrepresentation of gene
ontology (GO) terms (Lee et al., 2005). Another approach
was the gene-set enrichment analysis (GSEA). The GSEA
derives its power by focusing on gene sets, that is, groups
of genes that share common biological functions (e.g. bio-
chemical, metabolic or signal transduction routes), chromo-
somal location or regulation. The GSEA method ﬁrst
calculates an enrichment score (ES) that reﬂects the degree
to which a set of genes is overrepresented at the extremes
(top or bottom) of the entire list of genes. Then after, it
estimates the signiﬁcance level of ES by using an empirical
phenotype-based permutation test procedure that preserves
the complex correlation structure of the gene expression
data, and lastly there is an adjustment for multiple hypoth-
esis testing (Subramanian et al., 2005). Gene set size ﬁlter
considered a minimum of 15 and a maximum of 500 genes,
and the number of permutation was set to 1000. Gene sets
were considered signiﬁcantly enriched at a FDR, 5%. Nor-
malized enriched scores of signiﬁcantly enriched pathways
were calculated. Both applied methods have the advantage
that it is unbiased, because no gene selection step is used,
and a score is computed based on all genes in a GO term or
gene set. The last method used the Ingenuity Pathways
Analysis (IPA; version 5.5, Ingenuity Systems, Redwood City,
CA, USA) to identify the relevant molecular and cellular
functions, canonical pathways, biological functions and the
biological interaction networks among signiﬁcant genes. For
IPA analysis, the data set containing gene identiﬁers and
corresponding to an absolute threshold of FC of 1.3 and FDR
q-values ,0.05 was uploaded into the application. Each
identiﬁer was mapped to its corresponding gene object
in the Ingenuity knowledge base. To study the biological
interaction networks, genes were overlaid onto a global
molecular network developed from information contained in
the Ingenuity Pathways Knowledge Base. Networks of these
genes were then algorithmically generated based on their
connectivity. Network analysis returns a score that ranks
networks according to their degree of relevance to the net-
work eligible molecules in the data set (Calvano et al., 2005).
The network score is based on the hypergeometric distribu-
tion and is calculated with the right-tailed Fisher’s exact test.
The score is the negative log of this P-value. A score of 1.3
thus indicates a P-value of 0.05 and is considered statistically
signiﬁcant. Only those molecules that show relationships to
other genes, proteins or endogenous chemicals were inte-
grated into the analysis.
Results
DM intake, milk production and composition
Total estimated MR intake was 12.56 1.50 kg/day when
cows were fed with control diet and 14.76 1.50 kg/day
when cows were supplemented with UFA. Total DM intake
(DMI) was 15.1, 14.4, 14.5 and 14.7 kg/day for diets enriched
with rapeseed oil, soybean oil, linseed oil and a proportional
mix of them all, respectively, but the differences in DMI could
not be statistically evaluated as intake was not determined per
individual animal. Average pasture intake was 5.806 0.5 kg/
day for cows fed on control diet and 5.526 0.5 kg/day for
cows fed on UFA-enriched diet. The milk yield was 15%
greater (P, 0.05) when supplementing dairy cows with UFA
(27.66 1.26 kg/day) relative to the same cows fed the control
diet (23.46 1.26 kg/day), irrespective of the UFA source
(P. 0.10). Milk fat and protein yield did not differ between
treatments (1.006 0.05 and 0.916 0.05 kg/day, respectively).
Although lactose yield was greater (P, 0.01) for cows fed on
UFA-enriched diet (1.216 0.04 kg/day) compared with cows
fed on control diet (1.026 0.04 kg/day), the total milk fat
percentage was lower by over 20% (3.59% v. 4.30%6
0.60%; P, 0.05) and protein percentage was lower by over
6% (3.51% v. 3.75%6 0.41%; P, 0.05) for the same com-
parison. Lactose content was not different among treatments
(4.37%6 0.05%). In addition, throughout supplementation of
dietary UFA, the proportion of de novo FA decreased
(P, 0.001), and the proportion of LCFAs and trans-18 FA in
the milk increased (P, 0.001; Table 3). Further information of
dietary effects on milk FA proﬁles are given in the Supple-
mentary materials (Table S2 and Table S3).
Differential expression of genes in the mammary gland
We identiﬁed a total of 972 genes differentially expressed in
the mammary gland tissue of cows fed on a diet supple-
mented with UFA compared with the same cows receiving
the control diet. The list of differentially expressed genes
was generated using a cut-off of FDR q-values ,0.05
together with an absolute FC threshold of 1.3 and further
reﬁned by selecting those probe sets mapping to unique
Entrez Gene identiﬁers. The gene identiﬁcation, symbol and
description of these genes are shown in Supplementary
material (Table S4). Within these 972 genes, 312 upregu-
lated and 660 downregulated genes were found when
cows were supplemented with UFA compared with when
cows were fed the control diet. As gene expression was not
Table 3 FA proﬁle of milk when comparing dairy cows supplemented
with UFA relative to the same cows fed a control diet
Item (n5 28 cows) Control diet UFA-enriched diet s.e. P-value1
De novo FAs (%)2 41.2 35.6 1.03 ***
LCFA (%)3 50.0 56.1 0.98 ***
Total trans–FAs (%) 3.33 7.53 0.56 ***
c9,t11-CLA 0.57 0.99 0.093 ***
t10,c12-CLA 0.01 0.02 0.003 ***
FA5 fatty acid; UFA5 unsaturated fatty acids; LCFA5 long-chain FA;
CLA5Conjugated linoleic acid.
1P-value5 effect of UFA supplementation; *** levels of signiﬁcance indicate
P, 0.001.
2De novo FAs include all FAs from 4-C to 14-C and only 50% of 16-C FA.
3LCFA include all FAs with .18-C.
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Figure 1 Ingenuity Pathways Analysis (IPA) networks detected when comparing dairy cows supplemented with unsaturated fatty acid relative to the same cows
fed a control diet. (a) IPA network 1 included genes involved in cell cycle, cancer, cellular assembly and organization and presented a score of 46 and 33 focus genes;
(b) IPA network 2 included genes involved in cell-mediated immune response, cellular development and amino acid metabolism, with a score of 43 and 30 focus
genes; (c) IPA network 3 included genes involved in skeletal and muscular disorders, cell death, dermatological disease, with a score of 40 and 28 focus genes; and
(d) IPA network 4 included genes involved in connective tissue development and function, as well as tissue morphology and antigen presentation, with a score of
35 and 24 focus genes. The network displayed graphically as nodes (gene/gene products) and edges (the biological relationship between nodes). The node color
intensity indicates the expression of genes: red upregulated, green downregulated in animals supplemented with UFA relative to the same cows fed a control diet.
The shapes of nodes indicate the functional class of the gene product. The fold value and false discovery rate q-values are indicated under each node.
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signiﬁcantly affected in mammary gland of cows fed on
diets differing in the sources of dietary unprotected UFA
sources, we focused on the effect of UFA supplementation
(experimental period) on gene expression in the mammary
gland tissue, instead of the effect of different UFA sources.
To validate the microarray gene expression data, mammary
gland tissue RNA samples were analyzed by qRT-PCR for
the genes FASN, FADS1, FADS3 and SCD1. The qRT-PCR
results conﬁrmed the microarray expression levels for the
selected genes (Supplementary material, Table S5). In addi-
tion, correlations between qRT-PCR and microarray gene
expressions was consistently high, with most genes having
r2 values .0.70.
Functional clustering of differential expressed
genes in the mammary gland
To gain insight into the mammary gland tissue processes that
were altered during UFA supplementation, we tested the list
of differentially expressed genes using GO term enrichment
analysis (Supplementary material; Table S6), GSEA (Supple-
mentary material; Table S7) and IPA (Figure 1). One major
ﬁnding of all these approaches was that UFA supplementa-
tion mainly reduces expressions of genes involved in cellular
growth and proliferation, cytoskeleton organization and
cellular homeostasis, apoptosis, nutrient metabolism, as well
as molecular transport and defense response (Figure 2a).
Most of the genes included in these molecular and cellular
Figure 2 (a) Molecular and cellular functions signiﬁcantly modulated in the mammary gland tissue when comparing dairy cows supplemented with
unprotected unsaturated fatty acids (UFAs) relative to the same cows fed control diet. Statistical signiﬁcance of pathway modulation was calculated via a
right-tailed Fisher’s Exact test in Ingenuity Pathway and represented as –log (P-value): 2log values exceeding 1.30 were signiﬁcant false discovery rate
q-values ,0.05. (b) The downregulated and upregulated genes for each molecular pathway are presented. The color intensity indicates the expression of
genes: red upregulated, green downregulated in animals supplemented with UFA relative to the same cows fed a control diet.
Mach, Jacobs, Kruijt, van Baal and Smits
1224
Table 4 Lipid metabolism genes in mammary gland when comparing dairy cows supplemented with UFA relative to the same cows fed a control diet.
Lipid metabolism genes were identiﬁed by Ingenuity Pathways Analysis and they presented an absolute FC threshold of 1.3 and a FDR ,5%
Enrez ID Symbol Gene title FC1 FDR q-value2
NM_001046190 ABCD1 ATP-binding cassette, sub-family D, member 1 21.43 ***
NM_001034319 ACAA1 Acetyl-CoA acyltransferase 1 21.31 ***
NM_174224 ACACA Acetyl-CoA carboxylase-a 22.10 ***
XM_590080 ACOT4 Acyl-CoA thioesterase 1.32 ***
XM_613318 ACSM3 Acyl-CoA synthetase medium-chain family member 3 1.62 **
NM_174746 ACSS1 Acyl-CoA synthetase short-chain family member 1 21.37 ***
NM_001105339 ACSS2 Acyl-CoA synthetase short-chain family member 2 21.48 **
NM_001034055 ADIPOR1 Adiponectin receptor 1 21.36 ***
NM_177518 AGPAT1 1-acylglycerol-3-phosphate O-acyltransferase 1 21.96 ***
NM_174233 AGTR1 Angiotensin II receptor, type 1 1.36 ***
NM_173986 AKT1 v-akt murine thymoma viral oncogene homolog 1 21.99 ***
NM_001076293 ALOX5AP 5-lipoxygenase activating protein 1.45 ***
NM_001034523 AP2M1 Adaptor-related protein complex 2, m-1 subunit 21.64 ***
NM_174242 APOA1 Apolipoprotein A-I 1.37 ***
NM_173991 APOE Apolipoprotein E 21.65 **
NM_001040469 C3 Complement 3 21.72 ***
NM_174008 CD14 CD14 21.65 ***
NM_001001601 CDH5 Cadherin 5, type 2 21.37 ***
NM_173902 CLU Clusterin 21.49 **
XM_876020 CNTFR Cystic ﬁbrosis transmembrane conductance regulator 21.78 ***
NM_174035 CYBB Cytochrome b-245, b-polypeptide 1.39 ***
NM_001014927 DHCR7 7-dehydrocholesterol reductase 21.36 ***
NM_174308 EDNRA Endothelin receptor type A 1.40 ***
NM_174537 FCER1G Fc fragment of IgE, high afﬁnity I 21.49 ***
NM_001076014 FIG4 SAC1 lipid phosphatase domain 1.45 ***
NM_001034322 FKBP4 FK506 binding protein 4 21.33 ***
NM_176608 GHR Growth hormone 1.45 ***
NM_001034627 GSN Gelsolin (amyloidosis, ﬁnnish type) 21.45 ***
NM_174087 IGF2 Insulin-like growth factor 2 21.31 **
XM_869739 IL18BP Interleukin [IL]–18–binding protein 21.39 **
NM_001077909 INSIG1 Insulin-induced gene 1 21.49 ***
NM_175782 LGALS1 Lectin, galactoside binding, soluble, 1 1.36 ***
NM_001034768 LGALS4 Lectin, galactoside binding, soluble, 4 21.62 ***
NM_001103323 LIPA Lipase A 1.31 **
NM_174103_at LIPF Lipase, gastric 1.31 ***
XM_586851 LIPG Lipase G 21.79 ***
XM_865119 LPIN1 Lipin 1.59 ***
XM_614220 LRP5 Low-density lipoprotein receptor-related protein 5 21.76 ***
NM_180998 LTF Lactotransferrin 21.46 ***
NM_001080362 LYPLA2 Lysophospholipase II 21.35 ***
NM_175793 MAPK1 Mitogen-activated protein kinase 1 21.59 ***
XM_001255254 MAPKAPK2 Mitogen-activated protein kinase-activated protein kinase 2 21.33 ***
NM_001033608 MIF Macrophage migration inhibiting factor 23.61 ***
NM_001081605 MTMR3 Homo sapiens myotubularin related protein 3 21.31 ***
NM_174119 NCF1 Neutrophil cytosol factor 1 21.33 ***
NM_001014883 NR1H2 Nuclear receptor subfamily 1, group H, member 2 21.57 ***
NM_001083509 PCCA Propionyl CoA carboxylase, 1.35 ***
NM_001017953 PDGFB Platelet-derived growth factor b-polypeptide 21.48 ***
NM_174577 PI4KA Phosphatidylinositol 4-kinase 21.53 ***
NM_174783 PI4KB Phosphatidylinositol 4-kinase 21.31 ***
NM_174560_at PLA2G15 Phospholipase A2, group XV 1.31 ***
NM_001035390 POR P50 cytochrome oxidoreductase 21.36 ***
NM_001046005 PNPLA2 Patatin-like phospholipase domain containing protein 2 21.52 ***
NM_174161 PSAP Sphingolipid activator protein-1 21.63 ***
NM_174791 PTGDS Prostaglandin D2 synthase 21.51 **
NM_174443 PTGES Prostaglandin E synthase 21.67 ***
NM_001034310 PTTG1 Pituitary tumor-transforming 1 1.35 ***
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functions were downregulated during UFA supplementation
(Figure 2b). A speciﬁc examination of the lipid metabolism
IPA molecular and cellular function revealed that the SREBP1
was downregulated during UFA supplementation (Table 4).
Consequently, the expression of gene sets regulated by
SREBP1 were also downregulated (Table 4).
Interestingly, the canonical signaling pathways signiﬁcantly
modulated in the mammary gland tissue of dairy cows fed
on diets supplemented with UFA relative to the same cows
fed on control diet were mainly involved in cellular growth,
proliferation and development or immune system response
(Supplementary material; Figure S1). Those pathways asso-
ciated with cellular growth, proliferation and development,
included the mammalian target rapamycin (mTOR) signaling
pathways, the Janus kinases and signal transfers and activa-
tors of transcription (JAK/STAT) signaling pathways, as well
as the granulocyte-macrophage colony-stimulating factor
(GM-CSF) pathway (Supplementary material; Figure S2a).
Most of the genes included in these canonical pathways were
downregulated during UFA supplementation (Supplementary
material; Figure S2b). In addition, the main canonical path-
ways involved in immune response were related to interleukin
(IL) IL-2, IL-3, IL-8 and IL-6 signaling, as well as natural
killer cell signaling (Supplementary material; Figure S3a).
Remarkably, most of these canonical pathways included
downregulated genes when cows were supplemented with
UFA compared with when cows were fed with control diet
(Supplementary material; Figure S3b).
The IPA networks with the highest signiﬁcance score
(network score >35) are represented in Figure 1a to d. The
ﬁrst network (Figure 1a) presented a score of 46 and 33
focus genes. The major node that was identiﬁed during UFA
supplementation: tumor protein P53 (P53), is a key tran-
scription factor associated with mammary development
in ruminants (Piantoni et al., 2008). The second network
(Figure 1b), having a score of 43 and 30 focus genes, indi-
cated gene clusters centred on the serine/threonine-protein
phosphatase 2A, and peptidylprolylisomerase. This network
presents functions related to immune response, cellular
development and amino acid metabolism. The third IPA
network (Figure 1c), having a score of 40 and 28 focus
genes, centred on Ras. Members of the Ras family of small
GTPases function downstream of mitogenic growth factor
receptors and interact with a number of effectors to regulate
cell proliferation and survival (Swarbrick et al., 2008). The last
network (Figure 1d) involved genes associated with con-
nective tissue development and function, as well as tissue
morphology and antigen presentation, with a score of 35 and
24 focus genes. Figure 1d shows how UFA supplementation
could be related to genes that modulate the nuclear factor
kappa-light-chain-enhancer of activated B cells (NFkB), which
is a transcription regulator of genes encoding cytokines,
cytokine receptors and cell adhesion molecules that drive
immune and inﬂammatory responses (Sigal, 2006).
Discussion
Milk production and composition
Our study suggests that supplementing grazing dairy cows
with different unprotected UFA sources increases the milk
Table 4 Continued
Enrez ID Symbol Gene title FC1 FDR q-value2
NM_001100348 PXMP3 Peroxisomal membrane protein 3 1.37 ***
NM_001035081 RAB7A Member RAS oncogene family 21.67 ***
NM_001076945 SCD5 Stearoyl-CoA desaturase 5 1.30 ***
NM_174598 SCNN1A Socidum channel 22.84 ***
NM_173882 SERPINA1 Serpin peptidase inhibitor, clade A 21.63 ***
NM_174821 SERPING1 Serpin peptidase inhibitor, clade G 21.51 ***
NM_001082443 SIGIRR Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain 21.54 ***
NM_174782 SLC12A2 Solute carrier family 12 1.35 ***
NM_001034041 SNCA a-synuclein 1.52 ***
XM_870939 SPHK1 Sphingosine kinase 21.35 ***
NM_001099137 SRD5A1 Steroid-5-a-reductase, a-polypeptide 1 (3-oxo-5 a-steroid d-4-dehydrogenase-a-1) 21.48 ***
NM_001113302 SREBP1 Sterol regulatory element binding transcription factor 1 21.48 ***
NM_173960 SST Somatostatin 1.38 ***
NM_174617 STAT5B Signal transducer and activator of transcription 5 21.58 ***
NM_174674 TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A 21.52 ***
XM_583785 TNFSF10 Tumor necrosis factor (ligand) superfamily, member 10 21.82 ***
NM_174703 TNXB Tenascin XB 21.41 **
NM_174201 TP53 Tumor protein p53 21.48 ***
NM_175776 TSPO Translocator protein 21.38 ***
UFA5 unsaturated fatty acid; FC5 fold change; FDR5 false discovery rate; CoA5 coenzyme A.
1FCs were calculated considering gene expression when cows were fed with UFA-enriched diet compared with the same cows fed control diet.
2FDR q-value5 effect of UFA supplementation.
**, *** levels of signiﬁcance indicate P, 0.01 and P, 0.001, respectively.
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yield by 15%. This is in agreement with the study of Bu et al.
(2007), who reported that supplementing basal diet with
either 4.0% soybean oil, 4.0% linseed oil or 2.0% soybean
oil and 2.0% linseed oil, resulted in a milk yield increase
of 16.7% compared with the control treatment. The greater
energy density, protein content and starch content in the
enriched-UFA diet could have increased the availability of
glucose precursors for lactose synthesis in the mammary
gland. This, followed by the reduced NDF content, probably
stimulated milk production. However, because the control
period was conducted 28 days after UFA supplementa-
tion, the effects attributed to diet supplemented with UFA
may be confounded with effects due to a difference of
28 days in lactation stage. Therefore, isolation of the speciﬁc
effects of UFA supplementation on milk production and
composition may be complex and challenging to draw clear
conclusions.
The reduction in milk fat and protein percentage in cows
fed with UFA supplementation most likely resulted from a
dilution effect. However, the decreased milk fat and protein
contents, without modiﬁcations in lactose content, were
coupled with the decreased expression of genes associated
with the transport processes of nutrients, and with the
reduction of fat, and protein metabolism (see section ‘Effects
of UFA supplementation on nutrient metabolism’). Therefore,
these results suggested that the modiﬁcation of milk com-
ponents cannot be only accounted for the increase in milk
production but also for the decreased activities per cell.
Interestingly, the performance of cows fed on different plant
oil treatments were the same, suggesting that oils rich in
oleic (rapeseed oil), linoleic (soybean oil), ALA (linseed
oil) affected the performance of animals in a similar way.
Furthermore, cows fed on diets supplemented with different
unprotected UFA sources had increased proportion of LCFA
and c9,t11-CLA in milk but reduced de novo FA synthesis,
which in turn, improved the nutrition quality aspects of their
milk (Table 3, S2 and S3). It is well established that feed-
ing dairy cows with plant oils results in a reduction in the
de novo FA, and increases LCFA (Bauman and Griinari, 2003;
Bernard et al., 2008; Thering et al., 2009). Altered fermen-
tation of these plant oils results in rumen outﬂow of unique
biohydrogenation intermediates, some of which reduce lipid
synthesis in the mammary gland (Bauman and Griinari,
2003; Bauman et al., 2008). In particular, the trans-18:2 FA
has emerged as an important factor associated with the
inhibition of de novo FA synthesis (Bauman et al., 2006;
Harvatine et al., 2009).This study found similar results.
Therefore, it is likely that in our study the different unpro-
tected UFA sources had undergone ruminal biohydrogena-
tion, increasing the trans-FA and CLA isomers reaching the
mammary gland, which could be considered as an important
factor in the inhibition of the milk synthesis of de novo FA
proportion in milk. These observations, together with several
gene expression effects (see section ‘Effects of UFA supple-
mentation on nutrient metabolism’) are the major factors in
leading us to believe that the dietary UFA supplementation,
together with the higher energy and protein content, was
indeed the main factor affecting milk yield and composition,
rather than the lactation stage.
Differential gene expression of genes in the mammary gland
A total of 972 genes were differentially expressed in the
mammary gland tissue when supplementing grazing dairy
cows with UFA compared with when cows were fed with a
control diet, suggesting a large degree of transcriptomic
adaptation to the dietary UFAs. Similar to the milk production
and composition variables, we acknowledge that the effects
of UFA supplementation on gene expression might be con-
founded by lactation stage, but also by the different amount
of dietary protein and energy that was utilized by the cow.
There are no studies that report the effects of varying dietary
protein and energy levels on the genome-wide expression
in the mammary gland of dairy cows. Further, there are no
studies that describe the genome-wide expression in the
mammary gland of mid-lactation cows. However, Bionaz and
Loor (2008b) observed that the expression of 45 genes asso-
ciated with lipid synthesis and with well-deﬁned roles in
mammary lipid metabolism peaked at 60 days post partum,
and thereafter, their mRNA abundance decreased following
the lactation curve. As the mRNA expression of most of the
genes in our study presented different pattern from the
so-called lactation curve, it may be assumed that there is an
effect of enriched-UFA diet on their expression. Surprisingly,
expressions of genes in the mammary gland were not sig-
niﬁcantly different between UFA sources. A possible expla-
nation for these results might be that the variability in the
FA proﬁle among the dietary treatments was not sufﬁcient
because the unprotected UFA sources had undergone exten-
sive biohydrogenation by rumen microorganisms (Chilliard
et al., 2007); and therefore, the contrast in absorbed FA
composition between supplements was probably too small to
cause large differences in mammary gland tissue gene
expression. In agreement, Ollier et al. (2009) supplementing
mid-lactation multiparous goats with oil from whole intact
rapeseed or sunﬂower did not ﬁnd signiﬁcant changes in the
expression of 8382 genes in the mammary gland, despite
changes in milk composition. However, the lack of differently
expressed genes between UFA sources could also be the result
of a high variability in the expression levels of genes in the
mammary gland within groups of treatments, as biological
variation is intrinsic to all organisms (Churchill, 2002).
Functional clustering of differential expressed genes in the
mammary gland
The functional clustering of differentially expressed genes by
GO analysis, GSEA and IPA showed that supplementation
of UFA leads to downregulation of hundreds of genes that
modulate cellular growth proliferation and development cell
death, connections between cells and morphology (cytos-
keleton organization), apoptosis, cell cycle, nutrient meta-
bolism, as well as immune system response.
Effects of UFA supplementation on cellular growth pro-
liferation and development, cellular death, cytoskeleton
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organization and apoptosis. The downregulation of the
expression of key genes (P53, PPP2R1A and Ras) associatedwith
cellular growth, cell cycle, remodeling and apoptosis, as well as
canonical pathways such as mTOR and JAK/STAT signaling,
suggested changes in mammary gland tissue integrity and cell
adhesion when cows were supplemented with UFA-enriched
diets. The mTOR controls cellular metabolism, growth and pro-
liferation (Panasyuk et al., 2009), and the JAK/STAT pathway is
the principal signaling mechanism for a wide array of cytokines
and growth factors resulting in cell proliferation, differentiation,
cell migration and apoptosis (Rawlings et al., 2004). These
cellular events are critical to mammary gland lactation (Rawlings
et al., 2004). The information with regard to the effect of UFA
supplementation on regulation of genes functioning in remo-
deling of the mammary gland in dairy cows is lacking. However,
Connor et al. (2008) studying the speciﬁc mechanisms control-
ling the increase in milk production in dairy cows during the ﬁrst
few weeks of lactation, reported a downregulation of genes
functioning in remodeling of the mammary gland. Therefore, it
can be suggested that inhibition related to cell proliferation and
remodeling could be mainly occurring in response to UFA-
enriched diet that promoted an increase in milk synthesis.
Effects of UFA supplementation on immune system response.
We present some of the ﬁrst data in the bovine that reveal
changes in the expression of defense, inﬂammatory and
immune-related genes in response to UFA supplementation.
Cows fed with UFA-enriched diet revealed downregulation
of many key genes known to be involved in cellular and
humoral immune responses, as well as pathogen-induced
signaling and cellular stress and injury (Supplementary
material; Figure S3). It featured a number of genes involved
in cytokine and IL signaling, which exert potent chemo-
kinetic and chemotactic activity on leukocytes and enhance
the bactericidal activity of phagocytes in dairy cows (Pfafﬂ
et al., 2003), as well as T and B cell receptors, natural killer
cell signaling, GM-CSF signaling, C-C chemokine receptor
type 3 (CCR3) signaling in eosinophils, CXC chemokine
receptor 4 (CXCR4) signaling and integrin signaling. Lessard
et al. (2003) suggested that cellular immunity of the dairy
cows was affected by dietary supplementation of UFA. They
observed that 5 days after calving, the lymphocyte pro-
liferative response of cows allocated to linseed treatment was
reduced. Connor et al. (2008) reported that increasing milk
yield through milking frequency resulted in a downregulation
of several genes that function in innate immune response
and inﬂammation. Furthermore, one major ﬁnding of our
study was the downregulation of genes associated with NFkB
response after UFA supplementation (Figure 1d). In agree-
ment, Lessard et al. (2003) reported that dietary UFA can
affect the regulation of cytokine gene expression by mod-
ulating the activation of transcription nuclear factors such as
NFkB. Though little is known about the expression of defense,
inﬂammatory and immune-related genes in response to diet-
ary UFA supplementation in dairy cows, the results presented
here suggest that enriched-UFA diets may affect immune
functions of the mammary gland and thus may modify the
susceptibility to mastitis in lactating cows and the resulting
quality of milk. However, experiments speciﬁcally designed to
test these hypothesis are warranted to verify the roles of UFA
on genes involved in immune system response pathways and
networks, together with cell cycle, cell growth and certain
apoptotic pathways.
Effects of UFA supplementation on nutrient metabolism. Our
microarray data provide insight into the nutrient metabolism
adaptations in the mammary gland as a result of UFA sup-
plementation. Our ﬁnding suggested that through feeding
UFA-enriched diets, the mammary gland reduced overall fat
and protein metabolic activity, but increased carbohydrate
metabolism. Most of the transcripts involved with biological
process related to carbohydrate metabolism (glycolysis and
gluconeogenesis, and pentose phosphate pathway) were
upregulated (Figure 2b). Glucose is the major precursor for
synthesis of lactose, which controls milk volume by main-
taining the osmolarity of milk (Finucane et al., 2008). Con-
sistent to increased expression of genes associated with
carbohydrate metabolism, lactose and milk yield of cows
fed with enriched-UFA diet was greater relative to cows
fed with control diet. Under the conditions of this experi-
ment, increasing the fermentable energy content of the diet,
by reducing NDF and increasing starch was also likely to
stimulate the carbohydrate metabolism.
In contrast, supplementing basal diet of dairy cows with
unprotected UFA was characterized by substantial down-
regulation of the mRNA expression of genes in the mammary
gland involved in protein synthesis, protein trafﬁcking, protein
folding and the regulatory pathways controlling these pro-
cesses, as well as lipid, and transport processes of nutrients.
These changes may explain the reduction of fat and protein
percentages in milk of these dairy cows. The most prominent
functional characteristic of lipid metabolism category was the
downregulation of the transcription factor SREBP1, when
cows were supplemented with dietary unprotected UFA.
Therefore, these results suggested that increasing the LCFA
and trans-FA reaching mammary gland from blood may
affect expression of key transcription regulator genes and
their response genes. Together with the downregulation of
SREBP1, ACACA, which catalyzes the carboxylation of acetyl-
CoA to produce malonyl-CoA (Bernard et al., 2008), was
found to be downregulated during supplementation of UFA
(Table 4). These results support the hypothesis that regulation
of genes involved in de novo synthesis of FA is under control
of SREBP1 (Bionaz and Loor, 2008b). However, the observed
downregulation of de novo lipid biosynthesis in bovine
mammary gland could also be inﬂuenced by the down-
regulation of the insulin-induced gene (INSIG1; Raghow et al.,
2008). When cells have sufﬁcient sterol levels, INSIG1 retains
the SREBP1 cleavage-activating protein (SCAP)-SREBP1 in the
endoplasmic reticulum and consequently inhibits SREBP1-
mediated gene expression. On the basis of the above obser-
vations, it is tempting to speculate that UFA reaching the
mammary gland addresses the expression of both SREBP1
and INSIG1 to inhibit SREBP1-mediated gene expression and
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consequently, at least partially, reduce lipogenic activity in the
mammary gland. This is in agreement with Harvatine and
Bauman (2006), who reported that dietary treatments causing
milk fat depression decreased expression of SREBP1 and
the INSIG1, consistent with decreased abundance of active
SREBP1. Similarly, our ﬁndings underscore that supple-
mentation of dietary UFA decreased the expression of gene
sets regulated by PPARG, including those associated with FA
import (e.g. acetyl-CoA acyltransferase 1 (ACAA1)), activation
and intracellular channeling of FA (e.g. acyl-CoA synthetase
short-chain family member 1 and 2 (ACSS1 and ACSS2)) and
de novo FA synthesis (e.g. ACACA). Furthermore, the genes
related to the formation of triglyceride (TG) such as the acyl-
glycerol phosphate acyl-transferase (AGPAT1), thought to be
involved in catalyzing the initial step in the synthesis of
TG, were downregulated (Table 4). But on the contrary, our
data indicated that supplementation of dietary unprotected
UFA upregulated the expression of stearoyl-CoA desaturase 5
(SCD5), an isoform of the D-9 desaturase family (Lengi
and Corl, 2007). The role of SCD5 in the mammary tissue
remains elusive, although Gervais et al. (2009) reported
important differences between SCD1 and SCD5 regulation
and physiological roles when Holstein cows were infused
with a lipid emulsion enriched with t10,c12-CLA. However, no
effects on the expression of SCD1 were found in this study
(Supplementary material; Table S8). This is in agreement with
Delbecchi et al. (2001), who reported no differences in the
expression levels of SCD1 in the mammary gland when mid-
lactation Holstein cows were fed a total MR supplemented
with either 4.8% canola meal, 3.3% unprotected canola seeds
plus 1.5% canola meal or 4.8% formaldehyde-protected
canola seeds. Furthermore, Murrieta et al. (2006) also did not
report differences on SCD1mRNA expression in the mammary
gland of crossbred beef cows supplemented with cracked
safﬂower seed supplements. However, most of the studies
that examined the effect of milk fat depressing diets on SCD1
expression in the mammary gland, reported a tendency
toward reduction of mammary expression of SCD1 (Harvatine
and Bauman, 2006; Gervais et al., 2009).
Conclusions
The results of our study suggest that supplementing the diets
of grazing dairy cows with different unprotected UFAs
decreases milk fat and protein percentage, and increases
milk yield. Due to the UFA supplementation, the proportion
of LCFAs in milk increases, whereas de novo FA synthesis
decreases, which in turn, improves the nutrition quality
aspects of dairy milk. The UFA supplementation led to robust
transcriptional adaptations with 972 genes affected, sug-
gesting a strong impact on metabolism and other cellular
functions in the mammary gland. In particular, the functional
analysis on these genes indicated that inclusion of dietary
UFAs not only reduces the expression of genes associated
with lipid and protein metabolism, but unexpectedly also
of genes involved in cell–cell interactions, cells morphology
(cytoskeleton organization), cell death and immune response.
The large-scale transcriptional adaptations occurring in mam-
mary tissue in response to dietary lipids might provide the
basis for more detailed functional studies for future research.
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